Leaderboards/Hemoglobinopathies and Related Disorders

Hemoglobinopathies and Related Disorders

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Azalea Thomson
Institute for Health Metrics and Evaluation
2
Yuanyuan Tuo
Guiyang Medical University
3
Santosh Aiwale
Savitribai Phule Pune University
4
Chang Li
University of Washington Medical Center
5
Shang Ma
The University of Texas Southwestern Medical Center
6
Ziqian Xiang
Shanghai Jiao Tong University
7
Kelcee A. Everette
Broad Institute
8
Enrico Costa
Brigham and Women's Hospital
9
Krzysztof Badura
Medical University of Lodz
10
Archita Venugopal Menon
Beth Israel Deaconess Medical Center

Papers

1
Global, regional, and national burden of thalassemia, 1990–2021: a systematic analysis for the global burden of disease study 2021
EClinicalMedicine|2024
280 cit.
2
Non-invasive Anemia Detection and Prediagnosis
Journal of Pharmacology and Pharmacotherapeutics|2024
140 cit.
3
Piezo1 channel exaggerates ferroptosis of nucleus pulposus cells by mediating mechanical stress-induced iron influx
Bone Research|2024
94 cit.
4
Anemia of Chronic Kidney Disease—A Narrative Review of Its Pathophysiology, Diagnosis, and Management
Biomedicines|2024
78 cit.
5
Primary Electrical Heart Disease—Principles of Pathophysiology and Genetics
International Journal of Molecular Sciences|2024
29 cit.
6
Introducing a hemoglobin G-Makassar variant in HSCs by in vivo base editing treats sickle cell disease in mice
Molecular Therapy|2024
17 cit.
7
Uptake of orphan drugs in the WHO essential medicines lists
Bulletin of the World Health Organization|2024
16 cit.
8
Successes and pitfalls in orphan drug development for sickle cell disease
Blood Advances|2024
16 cit.
9
A simplified G-CSF–free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model
Blood Advances|2024
12 cit.
10
Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European Union
Journal of Cystic Fibrosis|2024
6 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Nicholas J Kassebaum
Institute for Health Metrics and Evaluation
2
Jonathan Yen
St. Jude Children's Research Hospital
3
Terri L. Russell
Emergency Nurses Association
4
Michael R. Schlabach
Q Therapeutics (United States)
5
Kirsty McHugh
University of Oxford
6
Niall Foy
Pfizer (Ireland)
7
Daniel P. Dever
Fondazione GraphiTech
8
N. A. Adesola Babarinde
Olabisi Onabanjo University
9
Mao Mao
BGI Group (China)
10
Vasco Meneghini
Vita-Salute San Raffaele University

Papers

1
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
The Lancet Haematology|2023
666 cit.
2
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
The Lancet Haematology|2023
551 cit.
3
Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation
PEDIATRICS|2022
507 cit.
4
Trends in the global, regional, and national burden of oral conditions from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
The Lancet|2025
278 cit.
5
Potent and uniform fetal hemoglobin induction via base editing
Nature Genetics|2023
75 cit.
6
Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
The Lancet|2024
64 cit.
7
Rational design of a SOCS1-edited tumor-infiltrating lymphocyte therapy using CRISPR/Cas9 screens
Journal of Clinical Investigation|2023
37 cit.
8
Prevalence, incidence, and years-lived with disability due to oral disorders in Brazil: an analysis of the Global Burden of Disease Study 2019
Revista da Sociedade Brasileira de Medicina Tropical|2022
19 cit.
9
Ultrasensitive Detection of COVID-19 Virus N Protein Based on p-Toluenesulfonyl Modified Fluorescent Microspheres Immunoassay
Biosensors|2022
9 cit.
10
Current dichotomous metrics obscure trends in severe and extreme child growth failure
Science Advances|2022
7 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Norman Arnheim
University of Southern California
2
Nancy C. Andrews
Boston Children's Hospital
3
Stuart H. Orkin
Howard Hughes Medical Institute
4
G. R. Serjeant
University of the West Indies System
5
Mark T. Gladwin
University of Maryland, Baltimore
6
Elliott Vichinsky
Unknown
7
Michael R. DeBaun
Vanderbilt University Medical Center
8
Tomas Ganz
University of California, Los Angeles
9
Russell E. Ware
Cincinnati Children's Hospital Medical Center
10
Dudley J. Pennell
Guy's and St Thomas' NHS Foundation Trust

Papers

1
Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell Anemia
Science|1985
9k cit.
2
Hematopoiesis: An Evolving Paradigm for Stem Cell Biology
Cell|2008
2.5k cit.
3
A rapid micrqpreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
Nucleic Acids Research|1991
2.3k cit.
4
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
Journal of Clinical Investigation|2004
2.2k cit.
5
Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver
Journal of Biological Chemistry|2001
2.2k cit.
6
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
Journal of Clinical Investigation|2004
2.1k cit.
7
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation
Nature Medicine|2003
1.8k cit.
8
Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy
The American Journal of Cardiology|2002
1.4k cit.
9
An early haematopoietic defect in mice lacking the transcription factor GATA-2
Nature|1994
1.4k cit.
10
Defensins. Natural peptide antibiotics of human neutrophils.
Journal of Clinical Investigation|1985
1.4k cit.

Reagents for Hemoglobinopathies and Related Disorders

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Mouse IGF-I Recombinant Protein

Cited in 8 papers
#19912$110
View Evidence →
Cell Signaling TechnologyEvidence 66

Syk (D1I5Q) Rabbit Monoclonal Antibody

Cited in 8 papers
#12358$161,351
View Evidence →
Cell Signaling TechnologyEvidence 60

RanBP1 Antibody

Cited in 7 papers
#8780$317
View Evidence →

🌟 All-Time

Most validated

Santa Cruz BiotechnologyEvidence 64

GATA-1 (N6)

Cited in 10 papers
#sc-265
View Evidence →
Cell Signaling Technology

NMDA Receptor 1 (GluN1) (D65B7) Rabbit Monoclonal Antibody

Cited in 9 papers
#5704$157,348
View Evidence →
Cell Signaling TechnologyEvidence 65

GM130 (D6B1) Rabbit Monoclonal Antibody (Alexa Fluor® 647 Conjugate)

Cited in 9 papers
#59890$465
View Evidence →